Policy perspective examines financial incentives tied to 10-year cardiovascular risk reduction across patient panels, highlighting potential strategies for value-based preventive healthcare.
This Viewpoint discusses whether financially rewarding reductions in 10-year predicted risk for atherosclerotic heart disease across a physician’s patient population is an effective model for value-based prevention.
No takes yet. Share an insight, caveat, or question.
Sanghavi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: